Literature DB >> 32228308

MiR-532-5p Suppresses Migration and Invasion of Lung Cancer Cells Through Inhibiting CCR4.

Jingjing Hu1, Lu Wang2, Caihong Guan3.   

Abstract

Background: Studies showed that miR-532-5p suppresses proliferation and induces apoptosis of lung cancer (LC) cells; its role in LC is not fully understood. Therefore, this research aimed to reveal the effect and mechanism of miR-532-5p on migration and invasion of LC cells. Materials and
Methods: The transfection efficiencies of miR-532-5p mimic, inhibitor, and overexpressed CCR4 were measured by quantitative real-time polymerase chain reaction (qRT-PCR). The relationships between miR-532-5p and CCR4 in A549 and SBC-5 cells were predicted by targetScan and verified by dual-luciferase reporter assay, Western blot, and qRT-PCR. Migration and invasion of cells transfected with miR-532-5p mimic, inhibitor, and CCR4 were determined by scratch test and transwell assay, respectively. The levels of epithelial-to-mesenchymal transition (EMT)-related proteins (E-cadherin (E-Cad)), N-catenin (N-Cad), and vimentin) in cells were measured by Western blot.
Results: MiR-532-5p mimic suppressed migration and invasion, while miR-532-5p inhibitor promoted migration and invasion of cells. CCR4 was a downstream target of miR-532-5p and both its protein and mRNA expressions were inhibited by miR-532-5p mimic, but promoted by miR-532-5p inhibitor. CCR4 promoted migration, invasion, and EMT process, and such effects of CCR4 were reversed by miR-532-5p mimic.
Conclusion: MiR-532-5p functioned as a cancer suppressor by negatively regulating CCR4 in LC cells, pointing to a potential protective mechanism of miR-532-5p to LC patients.

Entities:  

Keywords:  A549 cells; CCR4; MiR-532-5p; SBC-5 cells; invasion; migration

Mesh:

Substances:

Year:  2020        PMID: 32228308     DOI: 10.1089/cbr.2019.3258

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  5 in total

1.  Long Non-Coding RNA AL139385.1 as a Novel Prognostic Biomarker in Lung Adenocarcinoma.

Authors:  Xi Chen; Jishu Guo; Fan Zhou; Wenjun Ren; Xiaobin Huang; Jun Pu; Xiaoqun Niu; Xiulin Jiang
Journal:  Front Oncol       Date:  2022-05-16       Impact factor: 5.738

2.  Comprehensive Analysis of Ferroptosis- and Immune-Related Signatures to Improve the Prognosis and Diagnosis of Kidney Renal Clear Cell Carcinoma.

Authors:  Xiao-Liang Xing; Yan Liu; Jiheng Liu; Huanfa Zhou; Huirong Zhang; Qi Zuo; Ping Bu; Tong Duan; Yan Zhou; Zhiquan Xiao
Journal:  Front Immunol       Date:  2022-05-10       Impact factor: 8.786

3.  CircANTXR1 Contributes to the Malignant Progression of Hepatocellular Carcinoma by Promoting Proliferation and Metastasis.

Authors:  Changshan Huang; Wei Yu; Qian Wang; Tao Huang; Yuechao Ding
Journal:  J Hepatocell Carcinoma       Date:  2021-11-09

4.  Circular RNA ROCK1, a novel circRNA, suppresses osteosarcoma proliferation and migration via altering the miR-532-5p/PTEN axis.

Authors:  Yize Liu; Guanzhen Qiu; Yinzhou Luo; Shanshan Li; Yeqiu Xu; Yuanzhuang Zhang; Jiayuan Hu; Peifeng Li; Hai Pan; Yong Wang
Journal:  Exp Mol Med       Date:  2022-07-25       Impact factor: 12.153

5.  RNA Editing Enzyme ADAR1 Regulates METTL3 in an Editing Dependent Manner to Promote Breast Cancer Progression via METTL3/ARHGAP5/YTHDF1 Axis.

Authors:  Yi Li; Ning-Xi Wang; Chuan Yin; Shan-Shan Jiang; Jia-Chu Li; Sheng-Yong Yang
Journal:  Int J Mol Sci       Date:  2022-08-25       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.